Publications by authors named "Terry Furlong"

Claim this Profile
I
Impact of Donor Statin Treatment on Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.
Nahid Rashid, Ted Gooley, Terry Furlong, Stephanie J Lee, Paul J Martin

Transplant Cell Ther· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot study of lithium to restore intestinal barrier function in severe graft-versus-host disease.
Gideon Steinbach, David M Hockenbery, Gerwin Huls, Terry Furlong, David Myerson

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide.
Christopher G Kanakry, Javier Bolaños-Meade, Yvette L Kasamon, Marianna Zahurak, Nadira Durakovic, Terry Furlong

Blood· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation.
Marco Mielcarek, Terry Furlong, Paul V O'Donnell, Barry E Storer, Jeannine S McCune

Blood· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioning.
Christopher G Kanakry, Paul V O'Donnell, Terry Furlong, Marcos J de Lima, Wei Wei

J Clin Oncol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of oral beclomethasone dipropionate for prevention of acute graft-versus-host disease.
Paul J Martin, Terry Furlong, Scott D Rowley, Steven A Pergam, Michele Lloid

Biol Blood Marrow Transplant· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot pharmacologic biomarker study of busulfan and fludarabine in hematopoietic cell transplant recipients.
Jeannine S McCune, Erica L Woodahl, Terry Furlong, Barry Storer, Joanne Wang

Cancer Chemother Pharmacol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective comparison of tacrolimus versus cyclosporine with methotrexate for immunosuppression after allogeneic hematopoietic cell transplantation with mobilized blood cells.
Yoshihiro Inamoto, Mary E D Flowers, Frederick R Appelbaum, Paul A Carpenter, H Joachim Deeg, Terry Furlong

Biol Blood Marrow Transplant· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study.
Fabrizio Carnevale-Schianca, Wendy Leisenring, Paul J Martin, Terry Furlong, Gary Schoch

Biol Blood Marrow Transplant· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes.
Marco Mielcarek, Barry E Storer, Michael Boeckh, Paul A Carpenter, George B McDonald, Terry Furlong

Blood· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors.
Terry Furlong, Hans-Peter Kiem, Frederick R Appelbaum, Paul A Carpenter, H Joachim Deeg

Biol Blood Marrow Transplant· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation.
Richard A Nash, Laura Johnston, Pablo Parker, Jeannine S McCune, Barry Storer, Terry Furlong

Biol Blood Marrow Transplant· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease.
Terry Furlong, Wendy Leisenring, Rainer Storb, Claudio Anasetti, Frederick R Appelbaum

Biol Blood Marrow Transplant· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis